> top > docs > PMC:7029759 > spans > 15167-33636 > annotations

PMC:7029759 / 15167-33636 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
331 17-26 Species denotes 2019-nCoV Tax:2697049
334 88-97 Species denotes 2019-nCoV Tax:2697049
335 556-561 Species denotes Ebola Tax:1570291
350 1105-1136 Gene denotes angiotensin-converting enzyme 2 Gene:59272
351 1138-1142 Gene denotes ACE2 Gene:59272
352 1292-1296 Gene denotes ACE2 Gene:59272
353 1597-1601 Gene denotes ACE2 Gene:59272
354 1086-1095 Species denotes 2019-nCoV Tax:2697049
355 1213-1229 Species denotes SARS coronavirus Tax:694009
356 1271-1282 Species denotes coronavirus Tax:11118
357 1581-1590 Species denotes 2019-nCoV Tax:2697049
358 1709-1718 Species denotes 2019-nCoV Tax:2697049
359 1572-1576 Disease denotes SARS MESH:D045169
360 1679-1683 Disease denotes SARS MESH:D045169
361 1733-1737 Disease denotes SARS MESH:D045169
362 1856-1865 Disease denotes infection MESH:D007239
363 1869-1873 Disease denotes SARS MESH:D045169
365 1912-1916 Gene denotes ACE2 Gene:59272
371 2016-2020 Gene denotes ACE2 Gene:59272
372 2062-2066 Gene denotes ACE2 Gene:59272
373 1979-1987 Species denotes patients Tax:9606
374 2389-2404 Species denotes influenza virus Tax:11308
375 2519-2530 Chemical denotes sialic acid MESH:D019158
397 2626-2630 Gene denotes ACE2 Gene:59272
398 2771-2775 Gene denotes ACE2 Gene:59272
399 3021-3025 Gene denotes ACE2 Gene:59272
400 3268-3272 Gene denotes ACE2 Gene:59272
401 3315-3319 Gene denotes ACE2 Gene:59272
402 2705-2706 Gene denotes S Gene:43740568
403 2989-2997 Species denotes patients Tax:9606
404 3140-3149 Species denotes 2019-nCoV Tax:2697049
405 3227-3236 Species denotes 2019-nCoV Tax:2697049
406 3351-3362 Species denotes coronavirus Tax:11118
407 4287-4291 Species denotes mice Tax:10090
408 3346-3350 Species denotes NL63 Tax:277944
409 2700-2704 Disease denotes SARS MESH:D045169
410 2907-2911 Disease denotes SARS MESH:D045169
411 2962-2966 Disease denotes SARS MESH:D045169
412 3063-3072 Disease denotes infection MESH:D007239
413 3218-3222 Disease denotes SARS MESH:D045169
414 3337-3341 Disease denotes SARS MESH:D045169
415 4104-4108 Disease denotes MERS MESH:D018352
416 4114-4118 Disease denotes MERS MESH:D018352
417 4167-4182 Disease denotes viral infection MESH:D001102
419 4530-4539 Species denotes 2019-nCoV Tax:2697049
438 4586-4590 Gene denotes ACE2 Gene:59272
439 4719-4723 Gene denotes ACE2 Gene:59272
440 4978-4982 Gene denotes ACE2 Gene:59272
441 5077-5081 Gene denotes scFv Gene:652070
442 5113-5117 Gene denotes ACE2 Gene:59272
443 5300-5304 Gene denotes ACE2 Gene:59272
444 5361-5365 Gene denotes ACE2 Gene:59272
445 5263-5268 Gene denotes spike Gene:43740568
446 4902-4907 Gene denotes spike Gene:43740568
447 4662-4667 Gene denotes spike Gene:43740568
448 4640-4645 Species denotes human Tax:9606
449 4698-4709 Species denotes coronavirus Tax:11118
450 4929-4938 Species denotes 2019-nCoV Tax:2697049
451 5176-5187 Species denotes coronavirus Tax:11118
452 5218-5222 Gene denotes ACE2 Gene:59272
453 4727-4735 Disease denotes infected MESH:D007239
454 4836-4845 Disease denotes infection MESH:D007239
455 4921-4925 Disease denotes SARS MESH:D045169
468 5452-5456 Gene denotes ACE2 Gene:59272
469 5618-5622 Gene denotes ACE2 Gene:59272
470 5841-5845 Gene denotes ACE2 Gene:59272
471 6020-6024 Gene denotes ACE2 Gene:59272
472 6190-6194 Gene denotes ACE2 Gene:59272
473 6609-6613 Gene denotes scFv Gene:652070
474 6629-6633 Gene denotes ACE2 Gene:59272
475 6367-6376 Species denotes mammalian Tax:9606
476 6499-6507 Species denotes patients Tax:9606
477 5485-5504 Disease denotes 2019-nCoV infection MESH:C000657245
478 5563-5567 Disease denotes SARS MESH:D045169
479 6125-6137 Disease denotes inflammation MESH:D007249
503 7504-7508 Gene denotes ACE2 Gene:59272
504 7595-7599 Gene denotes ACE2 Gene:59272
505 7688-7692 Gene denotes ACE2 Gene:59272
506 7914-7918 Gene denotes ACE2 Gene:59272
507 8100-8104 Gene denotes ACE2 Gene:59272
508 8258-8262 Gene denotes ACE2 Gene:59272
509 8405-8409 Gene denotes ACE2 Gene:70008
510 8486-8490 Gene denotes ACE2 Gene:70008
511 8591-8595 Gene denotes ACE2 Gene:70008
512 7129-7138 Species denotes 2019-nCoV Tax:2697049
513 7298-7307 Species denotes 2019-nCoV Tax:2697049
514 8413-8419 Species denotes murine Tax:10090
515 8752-8760 Species denotes patients Tax:9606
516 6969-6973 Disease denotes SARS MESH:D045169
517 7044-7048 Disease denotes SARS MESH:D045169
518 7109-7118 Disease denotes infection MESH:D007239
519 7663-7672 Disease denotes infection MESH:D007239
520 8136-8145 Disease denotes infection MESH:D007239
521 8377-8381 Disease denotes SARS MESH:D045169
522 8476-8481 Disease denotes edema MESH:D004487
523 8537-8548 Disease denotes lung injury MESH:D055370
524 8653-8662 Disease denotes infection MESH:D007239
525 8704-8719 Disease denotes viral infection MESH:D001102
527 8812-8816 Gene denotes ACE2 Gene:59272
552 9081-9085 Gene denotes ACE2 Gene:59272
553 9280-9284 Gene denotes ACE2 Gene:59272
554 9404-9408 Gene denotes ACE2 Gene:59272
555 9565-9569 Gene denotes ACE2 Gene:59272
556 9587-9591 Gene denotes ACE2 Gene:59272
557 9665-9669 Gene denotes ACE2 Gene:59272
558 9737-9741 Gene denotes ACE2 Gene:59272
559 9963-9967 Gene denotes ACE2 Gene:59272
560 10021-10025 Gene denotes ACE2 Gene:59272
561 10177-10181 Gene denotes ACE2 Gene:59272
562 9422-9423 Gene denotes S Gene:43740568
563 9118-9119 Gene denotes S Gene:43740568
564 8946-8957 Species denotes coronavirus Tax:11118
565 9131-9140 Species denotes 2019-nCoV Tax:2697049
566 9212-9222 Species denotes SARS virus Tax:694009
567 9324-9334 Species denotes SARS virus Tax:694009
568 9530-9539 Species denotes 2019-nCoV Tax:2697049
569 9614-9622 Species denotes patients Tax:9606
570 10063-10079 Species denotes SARS coronavirus Tax:694009
571 10209-10218 Species denotes 2019-nCoV Tax:2697049
572 10247-10255 Species denotes patients Tax:9606
573 10002-10007 Species denotes human Tax:9606
574 9005-9013 Disease denotes infected MESH:D007239
575 9417-9421 Disease denotes SARS MESH:D045169
615 10290-10294 Gene denotes ACE2 Gene:59272
616 10347-10351 Gene denotes ACE2 Gene:59272
617 10653-10657 Gene denotes ACE2 Gene:59272
618 10679-10683 Gene denotes ACE2 Gene:59272
619 10796-10800 Gene denotes ACE2 Gene:59272
620 10872-10886 Gene denotes angiotensin II Gene:183
621 10981-10985 Gene denotes ACE2 Gene:59272
622 11145-11149 Gene denotes ACE2 Gene:59272
623 11411-11417 Gene denotes Ang1-8 Gene:284
624 11654-11658 Gene denotes ACE2 Gene:59272
625 10310-10311 Gene denotes S Gene:43740568
626 10300-10309 Species denotes 2019-nCoV Tax:2697049
627 10437-10445 Species denotes patients Tax:9606
628 11010-11037 Species denotes respiratory syncytial virus Tax:12814
629 11045-11049 Species denotes H5N1 Tax:102793
630 11139-11144 Species denotes human Tax:9606
631 11231-11239 Species denotes patients Tax:9606
632 11701-11710 Species denotes 2019-nCoV Tax:2697049
633 11711-11719 Species denotes patients Tax:9606
634 11050-11059 Species denotes influenza Tax:11320
635 11477-11488 Species denotes respiratory Tax:12814
636 11151-11157 Chemical denotes rhACE2
637 11270-11276 Chemical denotes rhACE2
638 11534-11540 Chemical denotes rhACE2
639 10397-10406 Disease denotes pneumonia MESH:D011014
640 10451-10455 Disease denotes SARS MESH:D045169
641 10460-10479 Disease denotes 2019-nCoV infection MESH:C000657245
642 10488-10497 Disease denotes pneumonia MESH:D011014
643 10525-10540 Disease denotes pulmonary edema MESH:D011654
644 10545-10580 Disease denotes acute respiratory distress syndrome MESH:D012128
645 10582-10586 Disease denotes ARDS MESH:D012128
646 10626-10630 Disease denotes ARDS MESH:D012128
647 10841-10852 Disease denotes lung injury MESH:D055370
648 11002-11006 Disease denotes ARDS MESH:D012128
649 11063-11072 Disease denotes infection MESH:D007239
650 11208-11212 Disease denotes ARDS MESH:D012128
651 11216-11230 Disease denotes critically ill MESH:D016638
652 11599-11603 Disease denotes ARDS MESH:D012128
653 11693-11697 Disease denotes ARDS MESH:D012128
763 15215-15224 Species denotes 2019-nCoV Tax:2697049
673 11814-11818 Gene denotes ACE2 Gene:59272
674 11913-11917 Gene denotes ACE2 Gene:59272
675 12047-12051 Gene denotes ACE2 Gene:59272
676 12126-12130 Gene denotes ACE2 Gene:59272
677 12318-12322 Gene denotes ACE2 Gene:59272
678 12398-12402 Gene denotes ACE2 Gene:59272
679 12501-12505 Gene denotes ACE2 Gene:59272
680 12569-12573 Gene denotes ACE2 Gene:59272
681 12468-12469 Gene denotes S Gene:43740568
682 12354-12355 Gene denotes S Gene:43740568
683 11746-11755 Species denotes 2019-nCoV Tax:2697049
684 11756-11764 Species denotes patients Tax:9606
685 11838-11843 Species denotes human Tax:9606
686 12344-12353 Species denotes 2019-nCoV Tax:2697049
687 12458-12467 Species denotes 2019-nCoV Tax:2697049
688 12606-12616 Species denotes SARS virus Tax:694009
689 12635-12644 Species denotes 2019-nCoV Tax:2697049
690 11967-11971 Disease denotes SARS MESH:D045169
691 12256-12267 Disease denotes lung injury MESH:D055370
694 12698-12702 Gene denotes ACE2 Gene:59272
695 12742-12763 Species denotes 2019-nCoV coronavirus Tax:2697049
705 12798-12802 Gene denotes ACE2 Gene:59272
706 12930-12934 Gene denotes ACE2 Gene:59272
707 12980-12984 Gene denotes ACE2 Gene:59272
708 13020-13024 Gene denotes ACE2 Gene:59272
709 13076-13080 Gene denotes ACE2 Gene:59272
710 12824-12829 Species denotes human Tax:9606
711 13070-13075 Species denotes human Tax:9606
712 13137-13142 Species denotes human Tax:9606
713 13253-13258 Species denotes human Tax:9606
745 13562-13566 Gene denotes ACE2 Gene:70008
746 13662-13666 Gene denotes ACE2 Gene:70008
747 13962-13966 Gene denotes CD16 Gene:2214
748 14339-14343 Gene denotes ACE2 Gene:59272
749 14812-14816 Gene denotes ACE2 Gene:59272
750 14859-14863 Gene denotes ACE2 Gene:59272
751 14946-14950 Gene denotes ACE2 Gene:59272
752 15132-15136 Gene denotes ACE2 Gene:59272
753 15296-15300 Gene denotes ACE2 Gene:59272
754 13515-13523 Species denotes patients Tax:9606
755 13625-13629 Species denotes mice Tax:10090
756 14157-14162 Species denotes mouse Tax:10090
757 14554-14563 Species denotes 2019-nCoV Tax:2697049
758 14739-14761 Species denotes human coronavirus NL63 Tax:277944
759 14806-14811 Species denotes human Tax:9606
760 14914-14923 Species denotes 2019-nCoV Tax:2697049
761 15072-15082 Species denotes SARS virus Tax:694009
762 15126-15131 Species denotes human Tax:9606
764 14797-14801 Species denotes NL63 Tax:277944
765 14835-14839 Species denotes NL63 Tax:277944
766 13506-13514 Disease denotes infected MESH:D007239
767 13714-13726 Disease denotes hypertension MESH:D006973
768 14003-14011 Disease denotes infected MESH:D007239
769 14152-14156 Disease denotes SARS MESH:D045169
770 14230-14234 Disease denotes SARS MESH:D045169
771 14482-14491 Disease denotes infection MESH:D007239
772 14713-14717 Disease denotes SARS MESH:D045169
773 14824-14828 Disease denotes SARS MESH:D045169
774 14881-14885 Disease denotes SARS MESH:D045169
775 15165-15174 Disease denotes infection MESH:D007239
800 15498-15501 Gene denotes CD4 Gene:920
801 15508-15511 Gene denotes CD4 Gene:920
802 15639-15651 Gene denotes CD4 receptor Gene:920
803 15675-15680 Gene denotes gp120 Gene:3700
804 15719-15722 Gene denotes CD4 Gene:920
805 15941-15944 Gene denotes CD4 Gene:920
806 16038-16042 Gene denotes CCR5 Gene:1234
807 15834-15842 Species denotes patients Tax:9606
808 16158-16173 Species denotes rhesus macaques Tax:9544
809 16196-16231 Species denotes simian-human immunodeficiency virus Tax:57667
810 16265-16274 Species denotes 2019-nCoV Tax:2697049
811 16454-16463 Species denotes 2019-nCoV Tax:2697049
812 16478-16487 Species denotes 2019-nCoV Tax:2697049
813 16556-16567 Species denotes respiratory Tax:12814
814 15569-15572 Species denotes HIV Tax:12721
815 15751-15754 Species denotes HIV Tax:12721
816 16134-16137 Species denotes HIV Tax:12721
817 16257-16260 Species denotes HIV Tax:12721
818 16388-16391 Species denotes HIV Tax:12721
819 16617-16620 Species denotes HIV Tax:12721
820 15699-15711 Disease denotes infected HIV MESH:D015658
821 15776-15785 Disease denotes infection MESH:D007239
822 16599-16608 Disease denotes infection MESH:D007239
823 16635-16652 Disease denotes chronic infection MESH:D007239
851 16730-16734 Gene denotes ACE2 Gene:59272
852 16795-16799 Gene denotes ACE2 Gene:59272
853 16952-16956 Gene denotes ACE2 Gene:59272
854 17091-17095 Gene denotes ACE2 Gene:59272
855 17261-17265 Gene denotes ACE2 Gene:59272
856 17355-17359 Gene denotes ACE2 Gene:59272
857 17587-17591 Gene denotes ACE2 Gene:59272
858 17697-17701 Gene denotes ACE2 Gene:59272
859 17821-17825 Gene denotes ACE2 Gene:59272
860 17925-17929 Gene denotes ACE2 Gene:59272
861 17991-17995 Gene denotes ACE2 Gene:59272
862 18158-18169 Gene denotes Fc receptor
863 18171-18175 Gene denotes CD16 Gene:2214
864 18451-18455 Gene denotes ACE2 Gene:59272
865 17506-17507 Gene denotes S Gene:43740568
866 17134-17142 Species denotes patients Tax:9606
867 17170-17178 Species denotes patients Tax:9606
868 17237-17246 Species denotes 2019-nCoV Tax:2697049
869 17247-17255 Species denotes patients Tax:9606
870 17496-17505 Species denotes 2019-nCoV Tax:2697049
871 18131-18140 Species denotes 2019-nCoV Tax:2697049
872 17647-17656 Chemical denotes histidine MESH:D006639
873 17184-17195 Disease denotes lung injury MESH:D055370
874 17487-17491 Disease denotes SARS MESH:D045169
875 17791-17795 Disease denotes SARS MESH:D045169
876 17942-17953 Disease denotes lung injury MESH:D055370
877 18254-18258 Disease denotes MERS MESH:D018352

LitCovid_Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T1 2519-2530 https://glytoucan.org/Structures/Glycans/G81533KY denotes sialic acid

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T569 10639-10644 NCBITaxon:10239 denotes viral
T568 10653-10657 G_3;PG_10;PR:000003622 denotes ACE2
T567 10679-10683 G_3;PG_10;PR:000003622 denotes ACE2
T566 10702-10712 GO:0010467 denotes expression
T565 10744-10753 PG_1 denotes S protein
T564 10796-10800 G_3;PG_10;PR:000003622 denotes ACE2
T563 10841-10845 UBERON:0002048 denotes lung
T562 10872-10886 PR:000036009;DG_37 denotes angiotensin II
T561 10933-10947 DG_37;PR:000001251 denotes angiotensin II
T560 10948-10964 PR:000001251 denotes type 1a receptor
T559 10981-10985 G_3;PG_10;PR:000003622 denotes ACE2
T558 11010-11021 UBERON:0001004;NCBITaxon:12814 denotes respiratory
T557 11022-11031 NCBITaxon:12814 denotes syncytial
T556 11032-11037 NCBITaxon:10239 denotes virus
T555 11139-11144 SP_6;NCBITaxon:9606;PG_10 denotes human
T554 11145-11149 PG_10;PR:000003622 denotes ACE2
T553 11324-11345 UBERON:0004535 denotes cardiovascular system
T552 11411-11415 PR:000004020 denotes Ang1
T551 11463-11473 GO:0065007 denotes modulation
T550 11477-11488 UBERON:0001004 denotes respiratory
T549 11627-11633 NCBITaxon:33208 denotes animal
T548 11654-11658 G_3;PG_10;PR:000003622 denotes ACE2
T547 11701-11710 SP_7 denotes 2019-nCoV
T546 11746-11755 SP_7 denotes 2019-nCoV
T545 11786-11799 GO:0005576 denotes extracellular
T544 11800-11806 SO:0000417 denotes domain
T543 11814-11818 G_3;PG_10;PR:000003622 denotes ACE2
T542 11838-11843 SP_6;NCBITaxon:9606 denotes human
T541 11844-11858 GO:0019814 denotes immunoglobulin
T540 11864-11870 SO:0000417 denotes domain
T539 11913-11917 G_3;PG_10;PR:000003622 denotes ACE2
T538 11967-11971 SP_10;PG_9 denotes SARS
T537 11972-11973 PG_9;PG_1 denotes S
T536 11974-11981 PG_1 denotes protein
T535 12026-12032 SO:0000417 denotes domain
T534 12047-12051 G_3;PG_10;PR:000003622 denotes ACE2
T533 12112-12125 GO:0005576 denotes extracellular
T532 12126-12130 G_3;PG_10 denotes ACE2
T531 12131-12137 SO:0000417 denotes domain
T530 12160-12169 PG_1 denotes S protein
T529 12256-12260 UBERON:0002048 denotes lung
T528 12318-12322 G_3;PG_10 denotes ACE2
T527 12323-12329 SO:0000417 denotes domain
T526 12344-12353 SP_7 denotes 2019-nCoV
T525 12354-12363 PG_1 denotes S protein
T524 12398-12402 G_3;PG_10;PR:000003622 denotes ACE2
T523 12458-12467 SP_7 denotes 2019-nCoV
T522 12468-12477 PG_1 denotes S protein
T521 12501-12505 G_3;PG_10;PR:000003622 denotes ACE2
T520 12569-12573 G_3;PG_10;PR:000003622 denotes ACE2
T519 12582-12589 SO:0000417 denotes domains
T518 12606-12610 SP_10;NCBITaxon:10633 denotes SARS
T517 12611-12616 NCBITaxon:10239 denotes virus
T516 12635-12644 SP_7 denotes 2019-nCoV
T515 13351-13357 SO:0000417 denotes domain
T514 13396-13400 CHEBI:23888;CHEBI:23888 denotes drug
T513 13464-13468 CHEBI:23888;CHEBI:23888 denotes drug
T512 13562-13566 G_3;PG_10;PR:000003622 denotes ACE2
T511 13625-13629 NCBITaxon:10088 denotes mice
T510 13662-13666 G_3;PG_10;PR:000003622 denotes ACE2
T509 13799-13807 CHEBI:35224;CHEBI:35224 denotes effector
T508 13828-13834 SO:0000417 denotes domain
T507 13861-13869 CHEBI:36357;CHEBI:36357 denotes molecule
T506 13895-13904 GO:0030425;CL:0000451 denotes dendritic
T505 13905-13910 CL:0000451 denotes cells
T504 13912-13923 CL:0000235 denotes macrophages
T503 13929-13949 CL:0000623 denotes natural killer cells
T502 13962-13966 PR:000001483 denotes CD16
T501 13984-13989 NCBITaxon:10239 denotes viral
T500 14079-14085 UBERON:0002405;GO:0006955 denotes immune
T499 14086-14094 GO:0006955 denotes response
T498 14118-14123 NCBITaxon:10239 denotes virus
T497 14152-14156 SP_10 denotes SARS
T496 14157-14162 NCBITaxon:10088 denotes mouse
T495 14187-14197 GO:0042571 denotes antibodies
T494 14230-14234 SP_10 denotes SARS
T493 14239-14252 GO:0001775 denotes activation of
T492 14253-14263 GO:0006909;CL:0000234 denotes phagocytic
T491 14264-14269 CL:0000234 denotes cells
T490 14282-14292 GO:0042571 denotes antibodies
T489 14310-14315 NCBITaxon:10239 denotes virus
T488 14339-14343 G_3;PG_10;PR:000003622 denotes ACE2
T487 14429-14437 GO:0042571 denotes antibody
T486 14554-14563 SP_7 denotes 2019-nCoV
T485 14696-14709 BV_19 denotes pathogenicity
T484 14713-14717 SP_10 denotes SARS
T483 14739-14744 SP_6;NCBITaxon:9606 denotes human
T482 14745-14756 NCBITaxon:11118 denotes coronavirus
T481 14806-14811 SP_6;NCBITaxon:9606;PG_10 denotes human
T480 14812-14816 PG_10;PR:000003622 denotes ACE2
T479 14824-14828 SP_10 denotes SARS
T478 14840-14849 PG_1 denotes S protein
T477 14859-14863 G_3;PG_10;PR:000003622 denotes ACE2
T476 14881-14885 SP_10;PG_9 denotes SARS
T475 14886-14887 PG_9;PG_1 denotes S
T474 14888-14895 PG_1 denotes protein
T473 14914-14923 SP_7 denotes 2019-nCoV
T472 14946-14950 G_3;PG_10;PR:000003622 denotes ACE2
T471 15030-15035 NCBITaxon:10239 denotes virus
T470 15072-15076 SP_10;NCBITaxon:10633 denotes SARS
T469 15077-15082 NCBITaxon:10239 denotes virus
T468 15126-15131 SP_6;NCBITaxon:9606;PG_10 denotes human
T467 15132-15136 PG_10;PR:000003622 denotes ACE2
T466 15215-15224 SP_7 denotes 2019-nCoV
T465 15296-15300 G_3;PG_10;PR:000003622 denotes ACE2
T464 15498-15501 PR:000001004 denotes CD4
T463 15508-15511 PR:000001004 denotes CD4
T462 15512-15515 GO:0071735 denotes IgG
T461 15624-15631 SO:0000417 denotes domains
T460 15639-15642 PR:000001004 denotes CD4
T459 15675-15680 PR:000003229 denotes gp120
T458 15688-15698 GO:0009986 denotes surface of
T457 15719-15722 PR:000001004 denotes CD4
T456 15723-15726 GO:0071735 denotes IgG
T455 15941-15944 PR:000001004 denotes CD4
T454 15945-15948 GO:0071735 denotes IgG
T453 16038-16042 PR:000001201 denotes CCR5
T452 16138-16146 SO:0001060 denotes isolates
T451 16158-16164 NCBITaxon:9654 denotes rhesus
T450 16165-16173 NCBITaxon:9539 denotes macaques
T449 16196-16202 NCBITaxon:10633 denotes simian
T448 16202-16203 NCBITaxon:57667 denotes -
T447 16203-16208 SP_6;NCBITaxon:9606 denotes human
T446 16226-16231 NCBITaxon:10633 denotes virus
T445 16265-16274 SP_7 denotes 2019-nCoV
T444 16294-16301 NCBITaxon:10239 denotes viruses
T443 16454-16463 SP_7 denotes 2019-nCoV
T442 16478-16487 SP_7 denotes 2019-nCoV
T441 16556-16567 NCBITaxon:11886;UBERON:0001004 denotes respiratory
T440 16568-16573 NCBITaxon:10239 denotes virus
T439 16730-16734 G_3;PG_10;PR:000003622 denotes ACE2
T438 16781-16794 GO:0005576 denotes extracellular
T437 16795-16799 G_3;PG_10;PR:000003622 denotes ACE2
T436 16895-16901 SO:0000417 denotes domain
T435 16938-16951 GO:0005576 denotes extracellular
T434 16952-16956 G_3;PG_10;PR:000003622 denotes ACE2
T433 16969-16977 GO:0032941 denotes secreted
T432 16981-16988 UBERON:0000479 denotes tissues
T431 17017-17030 GO:0005576 denotes extracellular
T430 17031-17037 SO:0000417 denotes domain
T429 17091-17095 G_3;PG_10;PR:000003622 denotes ACE2
T428 17184-17188 UBERON:0002048 denotes lung
T427 17237-17246 SP_7 denotes 2019-nCoV
T426 17261-17265 G_3;PG_10;PR:000003622 denotes ACE2
T425 17355-17359 G_3;PG_10;PR:000003622 denotes ACE2
T424 17487-17491 SP_10 denotes SARS
T423 17496-17505 SP_7 denotes 2019-nCoV
T422 17506-17515 PG_1 denotes S protein
T421 17587-17591 G_3;PG_10;PR:000003622 denotes ACE2
T404 1892-1898 CHEBI:38867;CHEBI:38867 denotes agents
T403 1912-1916 G_3;PG_10;PR:000003622 denotes ACE2
T402 2016-2020 G_3;PG_10;PR:000003622 denotes ACE2
T401 2062-2066 G_3;PG_10;PR:000003622 denotes ACE2
T400 2157-2162 CHEBI:52217;CHEBI:52217 denotes agent
T399 2178-2183 NCBITaxon:10239 denotes virus
T398 2389-2398 NCBITaxon:7719 denotes influenza
T397 2399-2404 NCBITaxon:10239 denotes virus
T396 2452-2460 GO:0042571 denotes antibody
T395 2519-2530 CHEBI:26667;CHEBI:26667 denotes sialic acid
T394 2543-2550 GO:0009986 denotes surface
T393 2626-2630 G_3;PG_10;PR:000003622 denotes ACE2
T392 2678-2684 SO:0000417 denotes domain
T391 2700-2704 SP_10;PG_9 denotes SARS
T390 2705-2706 PG_9;PG_1 denotes S
T389 2707-2714 PG_1 denotes protein
T388 2749-2755 SO:0000417 denotes domain
T387 2771-2775 G_3;PG_10;PR:000003622 denotes ACE2
T386 2825-2831 SO:0000417 denotes domain
T385 2907-2911 SP_10 denotes SARS
T384 2962-2966 SP_10 denotes SARS
T383 3021-3025 G_3;PG_10;PR:000003622 denotes ACE2
T382 3140-3149 SP_7 denotes 2019-nCoV
T381 3218-3222 SP_10 denotes SARS
T380 3227-3236 SP_7 denotes 2019-nCoV
T379 3252-3264 SO:0000409 denotes binding site
T378 3268-3272 G_3;PG_10;PR:000003622 denotes ACE2
T377 3315-3319 G_3;PG_10;PR:000003622 denotes ACE2
T376 3320-3333 SO:0000409 denotes binding sites
T375 3337-3341 SP_10 denotes SARS
T374 3351-3362 NCBITaxon:11118 denotes coronavirus
T373 3443-3453 GO:0042571 denotes antibodies
T372 3504-3511 UBERON:0000479 denotes tissues
T371 3540-3545 NCBITaxon:10239;GO:0035376 denotes viral
T370 3546-3551 GO:0035376 denotes entry
T369 3689-3697 NCBITaxon:2 denotes bacteria
T368 3760-3769 NCBITaxon:2 denotes bacterial
T367 4092-4098 SO:0000417 denotes domain
T366 4104-4108 SP_9 denotes MERS
T365 4114-4118 SP_9 denotes MERS
T364 4167-4172 NCBITaxon:10239;GO:0006260 denotes viral
T363 4233-4239 UBERON:0002405;GO:0006955 denotes immune
T362 4240-4248 GO:0006955 denotes response
T361 4271-4276 NCBITaxon:10239 denotes viral
T360 4277-4283 SO:0000417 denotes domain
T359 4287-4291 NCBITaxon:10088 denotes mice
T358 4398-4404 SO:0000417 denotes domain
T357 5424-5432 GO:0042571 denotes antibody
T356 5452-5456 G_3;PG_10;PR:000003622 denotes ACE2
T355 5485-5494 SP_7 denotes 2019-nCoV
T354 5563-5567 SP_10 denotes SARS
T353 5578-5589 GO:0006260 denotes replication
T352 5618-5622 G_3;PG_10;PR:000003622 denotes ACE2
T351 5623-5631 GO:0042571 denotes antibody
T350 5690-5700 GO:0042571 denotes antibodies
T349 5820-5825 NCBITaxon:10239 denotes viral
T348 5841-5845 G_3;PG_10;PR:000003622 denotes ACE2
T347 5854-5862 GO:0042571 denotes antibody
T346 5927-5936 PG_1 denotes S protein
T345 6020-6024 G_3;PG_10;PR:000003622 denotes ACE2
T344 6025-6033 GO:0042571 denotes antibody
T343 6048-6056 CHEBI:35224;CHEBI:35224 denotes effector
T342 6104-6110 SO:0000417 denotes domain
T341 6171-6178 UBERON:0000479 denotes tissues
T340 6179-6189 GO:0010467 denotes expressing
T339 6190-6194 G_3;PG_10;PR:000003622 denotes ACE2
T338 6251-6257 SO:0000417 denotes domain
T337 6324-6330 SO:0000417 denotes domain
T336 6367-6376 NCBITaxon:40674 denotes mammalian
T335 6377-6392 GO:0006412 denotes cell production
T334 6491-6495 CHEBI:23888;CHEBI:23888 denotes drug
T333 6629-6633 G_3;PG_10;PR:000003622 denotes ACE2
T332 6653-6660 SO:0000417 denotes domains
T331 6737-6745 NCBITaxon:2 denotes bacteria
T330 6814-6821 UBERON:0000479 denotes tissues
T329 6870-6879 CHEBI:36357;CHEBI:36357 denotes molecules
T328 6895-6901 SO:0000417 denotes domain
T327 6969-6973 SP_10 denotes SARS
T326 7021-7027 UBERON:0002405;GO:0006955 denotes immune
T325 7028-7036 GO:0006955 denotes response
T324 7044-7048 SP_10 denotes SARS
T323 7129-7138 SP_7 denotes 2019-nCoV
T322 7192-7198 UBERON:0002405;GO:0006955 denotes immune
T321 7199-7207 GO:0006955 denotes response
T320 7217-7224 NCBITaxon:10239 denotes viruses
T319 7298-7307 SP_7 denotes 2019-nCoV
T318 7321-7327 UBERON:0002405;GO:0006955 denotes immune
T317 7328-7336 GO:0006955 denotes response
T316 7504-7508 G_3;PG_10;PR:000003622 denotes ACE2
T315 7548-7554 UBERON:0000062 denotes organs
T314 7595-7599 G_3;PG_10;PR:000003622 denotes ACE2
T313 7688-7692 G_3;PG_10;PR:000003622 denotes ACE2
T312 7735-7739 UBERON:0002048 denotes lung
T311 7744-7760 UBERON:0001555 denotes gastrointestinal
T310 7761-7767 UBERON:0000062 denotes organs
T309 7779-7787 CL:0002139 denotes vascular
T308 7788-7799 CL:0002139;UBERON:0001986 denotes endothelial
T307 7800-7805 CL:0002139 denotes cells
T306 7818-7825 UBERON:0000479 denotes tissues
T305 7914-7918 G_3;PG_10;PR:000003622 denotes ACE2
T304 7935-7947 GO:0009986 denotes cell surface
T303 8100-8104 G_3;PG_10;PR:000003622 denotes ACE2
T302 8153-8158 UBERON:0000170 denotes lungs
T301 8188-8193 UBERON:0000170 denotes lungs
T300 8258-8262 G_3;PG_10;PR:000003622 denotes ACE2
T299 8299-8303 UBERON:0002048 denotes lung
T298 8377-8381 SP_10 denotes SARS
T297 8392-8398 SO:0000417 denotes domain
T296 8405-8409 G_3;PG_10;PR:000003622 denotes ACE2
T295 8413-8419 NCBITaxon:39107 denotes murine
T294 8420-8424 UBERON:0002048 denotes lung
T293 8425-8431 UBERON:0000479 denotes tissue
T292 8467-8475 UBERON:0003215 denotes alveolar
T291 8486-8490 G_3;PG_10;PR:000003622 denotes ACE2
T290 8537-8541 UBERON:0002048 denotes lung
T289 8591-8595 G_3;PG_10;PR:000003622 denotes ACE2
T288 8704-8709 NCBITaxon:10239 denotes viral
T287 88-97 SP_7 denotes 2019-nCoV
T286 149-154 NCBITaxon:10239 denotes virus
T285 194-204 GO:0042571 denotes antibodies
T284 299-309 GO:0042571 denotes antibodies
T283 367-375 GO:0042571 denotes antibody
T282 432-435 BV_22 denotes RNA
T281 436-441 BV_22;NCBITaxon:10239 denotes virus
T280 480-488 CHEBI:60004;CHEBI:60004 denotes cocktail
T279 489-497 GO:0042571 denotes antibody
T278 728-733 NCBITaxon:10239 denotes viral
T277 734-746 CHEBI:17089;BV_11;CHEBI:17089 denotes glycoprotein
T276 832-837 NCBITaxon:10239 denotes viral
T275 862-874 GO:0009986 denotes cell surface
T274 897-902 NCBITaxon:10239 denotes virus
T273 1008-1013 NCBITaxon:10239 denotes viral
T272 1086-1095 SP_7 denotes 2019-nCoV
T271 1105-1136 PG_10;PR:000003622 denotes angiotensin-converting enzyme 2
T270 1138-1142 G_3;PG_10;PR:000003622 denotes ACE2
T269 1213-1217 SP_10 denotes SARS
T268 1218-1229 NCBITaxon:11118 denotes coronavirus
T267 1258-1265 NCBITaxon:10239 denotes viruses
T266 1271-1282 NCBITaxon:11118 denotes coronavirus
T265 1292-1296 G_3;PG_10;PR:000003622 denotes ACE2
T264 1309-1318 PG_1 denotes S protein
T263 1346-1355 GO:0061025 denotes fusion of
T262 1360-1365 NCBITaxon:10239;GO:0036338 denotes viral
T261 1366-1374 GO:0036338 denotes membrane
T260 1379-1392 GO:0005886 denotes cell membrane
T259 1423-1426 BV_22 denotes RNA
T258 1427-1432 BV_22;NCBITaxon:10239 denotes virus
T257 1438-1447 GO:0006260 denotes replicate
T256 1452-1458 SO:0001026 denotes genome
T255 1521-1529 GO:0046903 denotes secreted
T254 1572-1576 SP_10 denotes SARS
T253 1581-1590 SP_7 denotes 2019-nCoV
T252 1597-1601 G_3;PG_10;PR:000003622 denotes ACE2
T251 1679-1683 SP_10 denotes SARS
T250 1709-1718 SP_7 denotes 2019-nCoV
T249 1733-1737 SP_10 denotes SARS
T248 1869-1873 SP_10 denotes SARS
T757 12698-12702 G_3;PG_10;PR:000003622 denotes ACE2
T756 12742-12751 SP_7 denotes 2019-nCoV
T755 12752-12763 NCBITaxon:11118 denotes coronavirus
T754 12774-12787 GO:0005576 denotes extracellular
T753 12788-12794 SO:0000417 denotes domain
T752 12798-12802 G_3;PG_10;PR:000003622 denotes ACE2
T751 12824-12829 SP_6;NCBITaxon:9606 denotes human
T750 12830-12844 GO:0019814 denotes immunoglobulin
T749 12848-12854 SO:0000417 denotes domain
T748 12891-12897 SO:0000417 denotes domain
T747 12910-12922 GO:0046983 denotes dimerization
T746 12930-12934 G_3;PG_10 denotes ACE2
T745 12935-12942 SO:0000417 denotes domains
T744 12980-12984 G_3;PG_10;PR:000003622 denotes ACE2
T743 13020-13024 G_3;PG_10 denotes ACE2
T742 13025-13031 SO:0000417 denotes domain
T741 13070-13075 SP_6;NCBITaxon:9606;PG_10 denotes human
T740 13076-13080 PG_10;PR:000003622 denotes ACE2
T739 13137-13142 SP_6;NCBITaxon:9606 denotes human
T738 13143-13157 GO:0019814 denotes immunoglobulin
T737 13253-13258 SP_6;NCBITaxon:9606 denotes human
T736 13259-13271 CHEBI:60816;CHEBI:60816 denotes immunoglobin
T735 4495-4501 CHEBI:52217;CHEBI:52217 denotes agents
T734 4530-4539 SP_7 denotes 2019-nCoV
T733 4575-4585 GO:0010467 denotes expressing
T732 4586-4590 G_3;PG_10;PR:000003622 denotes ACE2
T731 4599-4603 UBERON:0002048 denotes lung
T730 4608-4624 UBERON:0001555 denotes gastrointestinal
T729 4625-4632 UBERON:0000479 denotes tissues
T728 4640-4645 SP_6;NCBITaxon:9606 denotes human
T727 4683-4690 GO:0009986 denotes surface
T726 4698-4709 NCBITaxon:11118 denotes coronavirus
T725 4719-4723 G_3;PG_10;PR:000003622 denotes ACE2
T724 4754-4764 GO:0035376 denotes cell entry
T723 4882-4888 SO:0000417 denotes domain
T722 4921-4925 SP_10 denotes SARS
T721 4929-4938 SP_7 denotes 2019-nCoV
T720 4978-4982 G_3;PG_10;PR:000003622 denotes ACE2
T719 5033-5041 GO:0042571 denotes antibody
T718 5045-5051 SO:0000984 denotes single
T717 5058-5066 GO:0042571 denotes antibody
T716 5113-5117 G_3;PG_10;PR:000003622 denotes ACE2
T715 5176-5187 NCBITaxon:11118 denotes coronavirus
T714 5218-5222 G_3;PG_10;PR:000003622 denotes ACE2
T713 5223-5236 GO:0005576 denotes extracellular
T712 5237-5243 SO:0000417 denotes domain
T711 5284-5290 SO:0000417 denotes domain
T710 5300-5304 G_3;PG_10;PR:000003622 denotes ACE2
T709 5361-5365 G_3;PG_10;PR:000003622 denotes ACE2
T619 8812-8816 G_3;PG_10;PR:000003622 denotes ACE2
T618 8900-8908 GO:0042571 denotes antibody
T617 8914-8922 CHEBI:36357;CHEBI:36357 denotes molecule
T616 8946-8957 NCBITaxon:11118 denotes coronavirus
T615 9081-9085 G_3;PG_10;PR:000003622 denotes ACE2
T614 9118-9127 PG_1 denotes S protein
T613 9131-9140 SP_7 denotes 2019-nCoV
T612 9166-9171 NCBITaxon:10239 denotes virus
T611 9212-9216 SP_10;NCBITaxon:10633 denotes SARS
T610 9217-9222 NCBITaxon:10239 denotes virus
T609 9280-9284 G_3;PG_10;PR:000003622 denotes ACE2
T608 9324-9328 SP_10;NCBITaxon:10633 denotes SARS
T607 9329-9334 NCBITaxon:10239 denotes virus
T606 9404-9408 G_3;PG_10;PR:000003622 denotes ACE2
T605 9417-9421 SP_10;PG_9 denotes SARS
T604 9422-9423 PG_9;PG_1 denotes S
T603 9424-9431 PG_1 denotes protein
T602 9497-9507 GO:0042571 denotes antibodies
T601 9530-9539 SP_7 denotes 2019-nCoV
T600 9565-9569 G_3;PG_10;PR:000003622 denotes ACE2
T599 9587-9591 G_3;PG_10;PR:000003622 denotes ACE2
T598 9665-9669 G_3;PG_10;PR:000003622 denotes ACE2
T597 9711-9725 GO:0019814 denotes immunoglobulin
T596 9729-9735 SO:0000417 denotes domain
T595 9737-9741 G_3;PG_10;PR:000003622 denotes ACE2
T594 9769-9777 UBERON:0000104 denotes lifespan
T593 9797-9805 CHEBI:36357;CHEBI:36357 denotes molecule
T592 9829-9837 CHEBI:35224;CHEBI:35224 denotes effector
T591 9855-9868 UBERON:0002405 denotes immune system
T590 9881-9886 NCBITaxon:10239 denotes virus
T589 9911-9917 NCBITaxon:33208 denotes animal
T588 9963-9967 G_3;PG_10;PR:000003622 denotes ACE2
T587 9968-9981 GO:0005576 denotes extracellular
T586 9982-9988 SO:0000417 denotes domain
T585 10002-10007 SP_6;NCBITaxon:9606 denotes human
T584 10013-10019 SO:0000417 denotes domain
T583 10021-10025 G_3;PG_10;PR:000003622 denotes ACE2
T582 10063-10067 SP_10 denotes SARS
T581 10068-10079 NCBITaxon:11118 denotes coronavirus
T580 10177-10181 G_3;PG_10;PR:000003622 denotes ACE2
T579 10209-10218 SP_7 denotes 2019-nCoV
T578 10290-10294 G_3;PG_10;PR:000003622 denotes ACE2
T577 10300-10309 SP_7 denotes 2019-nCoV
T576 10310-10319 PG_1 denotes S protein
T575 10347-10351 G_3;PG_10;PR:000003622 denotes ACE2
T574 10451-10455 SP_10 denotes SARS
T573 10460-10469 SP_7 denotes 2019-nCoV
T572 10525-10534 UBERON:0002048 denotes pulmonary
T571 10551-10562 UBERON:0001004 denotes respiratory
T570 10598-10605 NCBITaxon:10239 denotes viruses
T420 17697-17701 G_3;PG_10;PR:000003622 denotes ACE2
T419 17702-17715 GO:0005576 denotes extracellular
T418 17716-17722 SO:0000417 denotes domain
T417 17791-17795 PR:000014459;SP_10;PG_9 denotes SARS
T416 17796-17797 PG_9;PG_1;PR:000005292 denotes S
T415 17798-17805 PG_1;PR:000005292 denotes protein
T414 17821-17825 G_3;PG_10;PR:000003622 denotes ACE2
T413 17925-17929 G_3;PG_10;PR:000003622 denotes ACE2
T412 17942-17946 UBERON:0002048 denotes lung
T411 17991-17995 G_3;PG_10;PR:000003622 denotes ACE2
T410 18088-18096 GO:0042571 denotes antibody
T409 18131-18140 SP_7 denotes 2019-nCoV
T408 18171-18175 PR:000001483 denotes CD16
T407 18240-18250 GO:0042571 denotes antibodies
T406 18254-18258 SP_9 denotes MERS
T405 18451-18455 G_3;PG_10;PR:000003622 denotes ACE2

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T71 169-174 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T72 229-233 Body_part denotes body http://purl.org/sig/ont/fma/fma256135
T73 367-375 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T74 432-435 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T75 489-497 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T76 734-746 Body_part denotes glycoprotein http://purl.org/sig/ont/fma/fma62925
T77 847-854 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T78 862-874 Body_part denotes cell surface http://purl.org/sig/ont/fma/fma67653
T79 862-866 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T80 1026-1030 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T81 1162-1166 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T82 1311-1318 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T83 1379-1392 Body_part denotes cell membrane http://purl.org/sig/ont/fma/fma63841
T84 1379-1383 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T85 1423-1426 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T86 1452-1458 Body_part denotes genome http://purl.org/sig/ont/fma/fma84116
T87 1470-1474 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T88 1546-1551 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T89 2067-2074 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T90 2452-2460 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T91 2538-2550 Body_part denotes cell surface http://purl.org/sig/ont/fma/fma67653
T92 2538-2542 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T93 2707-2714 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T94 2837-2848 Body_part denotes amino acids http://purl.org/sig/ont/fma/fma82739
T95 2915-2919 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T96 3026-3034 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257
T97 3045-3050 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T98 3504-3511 Body_part denotes tissues http://purl.org/sig/ont/fma/fma9637
T99 3630-3637 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T100 3797-3805 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257
T101 3974-3981 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T102 4081-4091 Body_part denotes amino acid http://purl.org/sig/ont/fma/fma82739
T103 4190-4194 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T104 4350-4355 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T105 4555-4560 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T106 4569-4574 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T107 4599-4603 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T108 4625-4632 Body_part denotes tissues http://purl.org/sig/ont/fma/fma9637
T109 4640-4650 Body_part denotes human body http://purl.org/sig/ont/fma/fma305853
T110 4668-4675 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T111 4736-4741 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T112 4754-4758 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T113 4908-4915 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T114 5033-5041 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T115 5058-5066 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T116 5269-5276 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T117 5424-5432 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T118 5457-5464 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T119 5623-5631 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T120 5854-5862 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T121 5929-5936 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T122 6025-6033 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T123 6171-6178 Body_part denotes tissues http://purl.org/sig/ont/fma/fma9637
T124 6377-6381 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T125 6814-6821 Body_part denotes tissues http://purl.org/sig/ont/fma/fma9637
T126 6992-6996 Body_part denotes body http://purl.org/sig/ont/fma/fma256135
T127 7049-7056 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T128 7526-7530 Body_part denotes body http://purl.org/sig/ont/fma/fma256135
T129 7710-7714 Body_part denotes body http://purl.org/sig/ont/fma/fma256135
T130 7735-7739 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T131 7788-7805 Body_part denotes endothelial cells http://purl.org/sig/ont/fma/fma66772
T132 7800-7805 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T133 7818-7825 Body_part denotes tissues http://purl.org/sig/ont/fma/fma9637
T134 7935-7947 Body_part denotes cell surface http://purl.org/sig/ont/fma/fma67653
T135 7935-7939 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T136 7995-8002 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T137 8153-8158 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T138 8188-8193 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T139 8299-8303 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T140 8366-8373 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T141 8420-8424 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T142 8425-8431 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T143 8467-8475 Body_part denotes alveolar http://purl.org/sig/ont/fma/fma264783
T144 8537-8541 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T145 8900-8908 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T146 8988-8993 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T147 9120-9127 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T148 9350-9355 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T149 9424-9431 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T150 9711-9725 Body_part denotes immunoglobulin http://purl.org/sig/ont/fma/fma62871
T151 9855-9868 Body_part denotes immune system http://purl.org/sig/ont/fma/fma9825
T152 10312-10319 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T153 10658-10665 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T154 10684-10691 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T155 10746-10753 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T156 10801-10808 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T157 10841-10845 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T158 10902-10910 Body_part denotes hormones http://purl.org/sig/ont/fma/fma12278
T159 11324-11345 Body_part denotes cardiovascular system http://purl.org/sig/ont/fma/fma7161
T160 11819-11826 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T161 11844-11860 Body_part denotes immunoglobulin G http://purl.org/sig/ont/fma/fma62872
T162 11918-11929 Body_part denotes amino acids http://purl.org/sig/ont/fma/fma82739
T163 11974-11981 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T164 12162-12169 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T165 12256-12260 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T166 12356-12363 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T167 12406-12414 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257
T168 12470-12477 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T169 12574-12581 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T170 12655-12660 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T171 12713-12720 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T172 12830-12844 Body_part denotes immunoglobulin http://purl.org/sig/ont/fma/fma62871
T173 12953-12963 Body_part denotes amino acid http://purl.org/sig/ont/fma/fma82739
T174 12995-13002 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T175 13044-13055 Body_part denotes amino acids http://purl.org/sig/ont/fma/fma82739
T176 13081-13088 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T177 13143-13159 Body_part denotes immunoglobulin G http://purl.org/sig/ont/fma/fma62872
T178 13895-13910 Body_part denotes dendritic cells http://purl.org/sig/ont/fma/fma273565
T179 13905-13910 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T180 13912-13923 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T181 13929-13949 Body_part denotes natural killer cells http://purl.org/sig/ont/fma/fma63147
T182 13944-13949 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T183 14012-14017 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T184 14264-14269 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T185 14354-14361 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T186 14429-14437 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T187 14616-14623 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T188 14649-14653 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T189 14842-14849 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T190 14888-14895 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T191 15512-15515 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872
T192 15569-15572 Body_part denotes HIV http://purl.org/sig/ont/fma/fma278683
T193 15592-15599 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T194 15708-15711 Body_part denotes HIV http://purl.org/sig/ont/fma/fma278683
T195 15712-15717 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T196 15723-15726 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872
T197 15751-15754 Body_part denotes HIV http://purl.org/sig/ont/fma/fma278683
T198 15791-15798 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T199 15945-15948 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872
T200 16134-16137 Body_part denotes HIV http://purl.org/sig/ont/fma/fma278683
T201 16257-16260 Body_part denotes HIV http://purl.org/sig/ont/fma/fma278683
T202 16318-16322 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T203 16388-16391 Body_part denotes HIV http://purl.org/sig/ont/fma/fma278683
T204 16617-16620 Body_part denotes HIV http://purl.org/sig/ont/fma/fma278683
T205 16834-16838 Body_part denotes body http://purl.org/sig/ont/fma/fma256135
T206 16981-16988 Body_part denotes tissues http://purl.org/sig/ont/fma/fma9637
T207 17096-17103 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T208 17184-17188 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T209 17337-17347 Body_part denotes amino acid http://purl.org/sig/ont/fma/fma82739
T210 17508-17515 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T211 17608-17615 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T212 17647-17656 Body_part denotes histidine http://purl.org/sig/ont/fma/fma82755
T213 17798-17805 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T214 17905-17912 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T215 17942-17946 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T216 18088-18096 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T217 18186-18191 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T8 4599-4603 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T9 7548-7554 Body_part denotes organs http://purl.obolibrary.org/obo/UBERON_0000062
T10 7735-7739 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T11 7761-7767 Body_part denotes organs http://purl.obolibrary.org/obo/UBERON_0000062
T12 8299-8303 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T13 8420-8424 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T14 8425-8431 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T15 8537-8541 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T16 9855-9868 Body_part denotes immune system http://purl.obolibrary.org/obo/UBERON_0002405
T17 10841-10845 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T18 11324-11345 Body_part denotes cardiovascular system http://purl.obolibrary.org/obo/UBERON_0004535
T19 12256-12260 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T20 17184-17188 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T21 17942-17946 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048

LitCovid_AGAC

Id Subject Object Predicate Lexical cue
p4504s27 4438-4447 NegReg denotes eliminate
p4551s19 10692-10701 NegReg denotes decreased
p4551s20 10702-10712 MPA denotes expression
p4580s38 14864-14870 MPA denotes levels
p4588s25 16044-16053 PosReg denotes enhancing
p4588s26 16054-16062 MPA denotes affinity
p4596s33 17723-17732 NegReg denotes abolished
p4596s34 17733-17742 Enzyme denotes peptidase
p4596s35 17743-17751 MPA denotes activity
p4596s39 17766-17770 MPA denotes high
p4596s40 17771-17779 MPA denotes affinity
p4596s41 17780-17787 Interaction denotes binding

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T42 556-561 Disease denotes Ebola http://purl.obolibrary.org/obo/MONDO_0005737
T43 1213-1217 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T44 1572-1576 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T45 1679-1683 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T46 1733-1737 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T47 1856-1865 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T48 1869-1873 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T49 2389-2398 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T50 2700-2704 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T51 2907-2911 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T52 2962-2966 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T53 3063-3072 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T54 3218-3222 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T55 3337-3341 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T56 4167-4182 Disease denotes viral infection http://purl.obolibrary.org/obo/MONDO_0005108
T57 4173-4182 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T58 4836-4845 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T59 4921-4925 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T60 5485-5504 Disease denotes 2019-nCoV infection http://purl.obolibrary.org/obo/MONDO_0100096
T61 5495-5504 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T62 5563-5567 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T63 6125-6137 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T64 6969-6973 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T65 7044-7048 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T66 7109-7118 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T67 7663-7672 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T68 8136-8145 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T69 8377-8381 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T70 8531-8548 Disease denotes acute lung injury http://purl.obolibrary.org/obo/MONDO_0006502|http://purl.obolibrary.org/obo/MONDO_0015796
T72 8542-8548 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T73 8653-8662 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T74 8704-8719 Disease denotes viral infection http://purl.obolibrary.org/obo/MONDO_0005108
T75 8710-8719 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T76 9212-9216 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T77 9324-9328 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T78 9417-9421 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T79 10026-10028 Disease denotes NN http://purl.obolibrary.org/obo/MONDO_0009747
T80 10063-10067 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T81 10397-10406 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T82 10451-10455 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T83 10460-10479 Disease denotes 2019-nCoV infection http://purl.obolibrary.org/obo/MONDO_0100096
T84 10470-10479 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T85 10488-10497 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T86 10525-10540 Disease denotes pulmonary edema http://purl.obolibrary.org/obo/MONDO_0006932
T87 10545-10580 Disease denotes acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T88 10551-10580 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T89 10582-10586 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T90 10626-10630 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T91 10835-10852 Disease denotes acute lung injury http://purl.obolibrary.org/obo/MONDO_0006502|http://purl.obolibrary.org/obo/MONDO_0015796
T93 10846-10852 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T94 11002-11006 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T95 11050-11059 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T96 11063-11072 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T97 11208-11212 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T98 11599-11603 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T99 11693-11697 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T100 11967-11971 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T101 12261-12267 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T102 12606-12610 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T103 13714-13726 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T104 14152-14156 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T105 14230-14234 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T106 14482-14491 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T107 14713-14717 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T108 14824-14828 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T109 14881-14885 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T110 15072-15076 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T111 15165-15174 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T112 15776-15785 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T113 16209-16225 Disease denotes immunodeficiency http://purl.obolibrary.org/obo/MONDO_0021094
T114 16599-16608 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T115 16643-16652 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T116 17189-17195 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T117 17487-17491 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T118 17791-17795 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T119 17947-17953 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T125 149-154 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T126 169-174 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T127 344-345 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T128 389-390 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T129 436-441 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T130 478-479 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T131 775-776 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T132 862-866 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T133 897-902 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T134 1026-1030 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T135 1040-1041 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T136 1147-1148 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T137 1162-1166 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T138 1173-1175 http://purl.obolibrary.org/obo/CLO_0053794 denotes 41
T139 1258-1265 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T140 1366-1374 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T141 1379-1383 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T142 1384-1392 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T143 1427-1432 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T144 1470-1474 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T145 1546-1551 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T146 2178-2183 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T147 2399-2404 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T148 2502-2509 http://purl.obolibrary.org/obo/CLO_0009985 denotes focuses
T149 2538-2542 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T150 2720-2723 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T151 2858-2861 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T152 2915-2919 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T153 3045-3050 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T154 3177-3178 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T155 3562-3564 http://purl.obolibrary.org/obo/CLO_0053799 denotes 45
T156 3689-3697 http://purl.obolibrary.org/obo/NCBITaxon_2 denotes bacteria
T157 3824-3825 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T158 3892-3895 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T159 3923-3935 http://purl.obolibrary.org/obo/OBI_0000245 denotes organization
T160 4006-4008 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T161 4123-4125 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T162 4190-4194 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T163 4319-4321 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T164 4350-4355 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T165 4395-4397 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T166 4448-4450 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T167 4468-4470 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48
T168 4555-4560 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T169 4569-4574 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T170 4599-4603 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T171 4599-4603 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T172 4640-4645 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T173 4736-4741 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T174 4754-4758 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T175 5142-5143 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T176 5281-5283 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T177 5366-5368 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T178 5371-5372 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T179 5729-5738 http://purl.obolibrary.org/obo/CLO_0036932 denotes hybridoma
T180 5768-5769 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T181 5948-5949 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T182 6101-6103 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T183 6248-6250 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T184 6321-6323 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T185 6350-6351 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T186 6377-6381 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T187 6575-6576 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T188 6635-6636 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T189 6737-6745 http://purl.obolibrary.org/obo/NCBITaxon_2 denotes bacteria
T190 6892-6894 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T191 7217-7224 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T192 7397-7398 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T193 7419-7420 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T194 7440-7442 http://purl.obolibrary.org/obo/CLO_0001407 denotes 52
T195 7548-7554 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organs
T196 7735-7739 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T197 7735-7739 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T198 7761-7767 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organs
T199 7788-7805 http://purl.obolibrary.org/obo/CL_0000115 denotes endothelial cells
T200 7935-7939 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T201 8153-8158 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T202 8188-8193 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T203 8299-8303 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T204 8299-8303 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T205 8338-8339 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T206 8357-8358 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T207 8389-8391 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T208 8420-8424 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T209 8420-8424 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T210 8537-8541 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T211 8537-8541 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T212 8669-8670 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T213 8840-8841 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T214 8988-8993 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T215 9056-9057 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T216 9166-9171 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T217 9217-9222 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T218 9329-9334 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T219 9350-9355 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T220 9540-9543 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T221 9595-9596 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T222 9726-9728 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T223 9742-9744 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T224 9855-9868 http://purl.obolibrary.org/obo/UBERON_0002405 denotes immune system
T225 9881-9886 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T226 9898-9904 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T227 9911-9917 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T228 9925-9926 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T229 10002-10007 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T230 10095-10096 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T231 10182-10184 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T232 10298-10299 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T233 10424-10425 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T234 10598-10605 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T235 10809-10812 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T236 10841-10845 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T237 10841-10845 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T238 11032-11037 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T239 11139-11144 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T240 11241-11242 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T241 11324-11345 http://purl.obolibrary.org/obo/UBERON_0004535 denotes cardiovascular system
T242 11324-11345 http://www.ebi.ac.uk/efo/EFO_0000791 denotes cardiovascular system
T243 11350-11351 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T244 11418-11425 http://purl.obolibrary.org/obo/PR_000018263 denotes peptide
T245 11556-11559 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T246 11627-11633 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T247 11659-11661 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T248 11836-11837 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T249 11838-11843 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T250 11861-11863 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T251 11880-11882 http://purl.obolibrary.org/obo/CLO_0001236 denotes 2A
T252 11930-11932 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T253 12087-12088 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T254 12188-12189 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T255 12224-12232 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T256 12256-12260 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T257 12256-12260 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T258 12403-12405 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T259 12611-12616 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T260 12655-12660 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T261 12703-12705 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T262 12724-12725 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T263 12767-12768 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T264 12824-12829 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T265 12845-12847 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T266 12888-12890 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T267 12946-12947 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T268 12985-12987 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T269 13056-13058 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T270 13070-13075 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T271 13137-13142 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T272 13227-13228 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T273 13239-13245 http://purl.obolibrary.org/obo/SO_0000418 denotes signal
T274 13251-13252 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T275 13253-13258 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T276 13348-13350 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T277 13370-13371 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T278 13648-13649 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T279 13667-13669 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T280 13681-13682 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T281 13825-13827 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T282 13895-13910 http://purl.obolibrary.org/obo/CL_0000451 denotes dendritic cells
T283 13929-13949 http://purl.obolibrary.org/obo/CL_0000623 denotes natural killer cells
T284 14012-14017 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T285 14046-14056 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T286 14118-14123 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T287 14150-14151 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T288 14157-14162 http://purl.obolibrary.org/obo/CLO_0007836 denotes mouse
T289 14175-14177 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T290 14239-14249 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T291 14253-14263 http://purl.obolibrary.org/obo/CL_0000234 denotes phagocytic
T292 14264-14269 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T293 14310-14315 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T294 14344-14346 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T295 14402-14403 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T296 14462-14463 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T297 14649-14653 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T298 14672-14675 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T299 14739-14744 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T300 14777-14778 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T301 14806-14811 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T302 15012-15013 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T303 15030-15035 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T304 15077-15082 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T305 15126-15131 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T306 15275-15280 http://purl.obolibrary.org/obo/UBERON_0001456 denotes faced
T307 15301-15303 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T308 15328-15329 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T309 15411-15412 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T310 15442-15443 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T311 15498-15501 http://purl.obolibrary.org/obo/PR_000001004 denotes CD4
T312 15502-15504 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T313 15508-15511 http://purl.obolibrary.org/obo/PR_000001004 denotes CD4
T314 15557-15558 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T315 15639-15642 http://purl.obolibrary.org/obo/PR_000001004 denotes CD4
T316 15712-15717 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T317 15719-15722 http://purl.obolibrary.org/obo/PR_000001004 denotes CD4
T318 15941-15944 http://purl.obolibrary.org/obo/PR_000001004 denotes CD4
T319 15992-15993 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T320 16000-16007 http://purl.obolibrary.org/obo/PR_000018263 denotes peptide
T321 16104-16112 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T322 16158-16173 http://purl.obolibrary.org/obo/NCBITaxon_9544 denotes rhesus macaques
T323 16203-16208 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T324 16226-16231 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T325 16247-16249 http://purl.obolibrary.org/obo/CLO_0054055 denotes 71
T326 16294-16301 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T327 16318-16328 http://purl.obolibrary.org/obo/CL_0000000 denotes cell types
T328 16427-16428 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T329 16568-16573 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T330 16735-16737 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T331 16871-16872 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T332 16892-16894 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T333 17146-17147 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T334 17184-17188 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T335 17184-17188 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T336 17199-17200 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T337 17266-17268 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T338 17370-17378 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T339 17743-17751 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T340 17942-17946 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T341 17942-17946 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T342 18003-18011 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T343 18158-18160 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T344 18186-18191 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T345 18199-18202 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T346 18456-18458 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T57 734-746 Chemical denotes glycoprotein http://purl.obolibrary.org/obo/CHEBI_17089
T58 847-854 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T59 1105-1116 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T60 1311-1318 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T61 2067-2074 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T62 2519-2530 Chemical denotes sialic acid http://purl.obolibrary.org/obo/CHEBI_26667
T63 2526-2530 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T64 2707-2714 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T65 2837-2848 Chemical denotes amino acids http://purl.obolibrary.org/obo/CHEBI_33709
T66 2837-2842 Chemical denotes amino http://purl.obolibrary.org/obo/CHEBI_46882
T67 2843-2848 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T68 3026-3034 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080
T69 3630-3637 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T70 3797-3805 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080
T71 3974-3981 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T72 4081-4091 Chemical denotes amino acid http://purl.obolibrary.org/obo/CHEBI_33709
T73 4081-4086 Chemical denotes amino http://purl.obolibrary.org/obo/CHEBI_46882
T74 4087-4091 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T75 4668-4675 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T76 4908-4915 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T77 5269-5276 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T78 5457-5464 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T79 5929-5936 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T80 6048-6056 Chemical denotes effector http://purl.obolibrary.org/obo/CHEBI_35224
T81 6491-6495 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T82 6870-6879 Chemical denotes molecules http://purl.obolibrary.org/obo/CHEBI_25367
T83 7049-7056 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T84 7995-8002 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T85 8366-8373 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T86 8914-8922 Chemical denotes molecule http://purl.obolibrary.org/obo/CHEBI_25367
T87 9120-9127 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T88 9424-9431 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T89 9797-9805 Chemical denotes molecule http://purl.obolibrary.org/obo/CHEBI_25367
T90 9829-9837 Chemical denotes effector http://purl.obolibrary.org/obo/CHEBI_35224
T91 10026-10028 Chemical denotes NN http://purl.obolibrary.org/obo/CHEBI_73406
T92 10312-10319 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T93 10658-10665 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T94 10684-10691 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T95 10746-10753 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T96 10801-10808 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T97 10872-10886 Chemical denotes angiotensin II http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506
T100 10872-10883 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T101 10884-10886 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T102 10902-10910 Chemical denotes hormones http://purl.obolibrary.org/obo/CHEBI_24621
T103 10933-10947 Chemical denotes angiotensin II http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506
T106 10933-10944 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T107 10945-10947 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T108 11358-11360 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T109 11418-11425 Chemical denotes peptide http://purl.obolibrary.org/obo/CHEBI_16670
T110 11819-11826 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T111 11918-11929 Chemical denotes amino acids http://purl.obolibrary.org/obo/CHEBI_33709
T112 11918-11923 Chemical denotes amino http://purl.obolibrary.org/obo/CHEBI_46882
T113 11924-11929 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T114 11974-11981 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T115 12162-12169 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T116 12356-12363 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T117 12406-12414 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080
T118 12470-12477 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T119 12574-12581 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T120 12713-12720 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T121 12953-12963 Chemical denotes amino acid http://purl.obolibrary.org/obo/CHEBI_33709
T122 12953-12958 Chemical denotes amino http://purl.obolibrary.org/obo/CHEBI_46882
T123 12959-12963 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T124 12995-13002 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T125 13044-13055 Chemical denotes amino acids http://purl.obolibrary.org/obo/CHEBI_33709
T126 13044-13049 Chemical denotes amino http://purl.obolibrary.org/obo/CHEBI_46882
T127 13050-13055 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T128 13081-13088 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T129 13396-13400 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T130 13464-13468 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T131 13799-13807 Chemical denotes effector http://purl.obolibrary.org/obo/CHEBI_35224
T132 13861-13869 Chemical denotes molecule http://purl.obolibrary.org/obo/CHEBI_25367
T133 14069-14078 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T134 14354-14361 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T135 14616-14623 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T136 14842-14849 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T137 14888-14895 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T138 15454-15463 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T139 15592-15599 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T140 15791-15798 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T141 16000-16007 Chemical denotes peptide http://purl.obolibrary.org/obo/CHEBI_16670
T142 17096-17103 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T143 17207-17209 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T144 17337-17347 Chemical denotes amino acid http://purl.obolibrary.org/obo/CHEBI_33709
T145 17337-17342 Chemical denotes amino http://purl.obolibrary.org/obo/CHEBI_46882
T146 17343-17347 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T147 17508-17515 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T148 17608-17615 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T149 17647-17656 Chemical denotes histidine http://purl.obolibrary.org/obo/CHEBI_27570
T150 17798-17805 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T151 17905-17912 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T10 4167-4182 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infection
T11 4233-4248 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T12 6125-6137 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T13 6419-6432 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylation
T14 7021-7036 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T15 7192-7207 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T16 7321-7336 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T17 8704-8719 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infection
T18 13229-13238 http://purl.obolibrary.org/obo/GO_0046903 denotes secretion
T19 14079-14094 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T20 17360-17378 http://purl.obolibrary.org/obo/GO_0008233 denotes peptidase activity
T21 17733-17751 http://purl.obolibrary.org/obo/GO_0008233 denotes peptidase activity

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T94 0-36 Sentence denotes Proposal for new 2019-nCoV therapies
T95 37-237 Sentence denotes The simplest and most direct approach to combating 2019-nCoV during the outbreak would be one to neutralize the virus from entering cells, the function that antibodies normally perform in the body 39.
T96 238-477 Sentence denotes For the reasons mentioned above when discussing neutralizing antibodies, it will be difficult to validate a broadly neutralizing antibody quickly, and a challenge to make sure that the mutating RNA virus will not escape its neutralization.
T97 478-629 Sentence denotes A cocktail antibody approach could be undertaken as was explored to treat the Ebola pandemic 40, but would add complexity to the manufacturing process.
T98 630-756 Sentence denotes However, there is another strategy to pursue in this scenario that does not rely on targeting the viral glycoprotein directly.
T99 757-940 Sentence denotes In this strategy, a neutralizing effect could be obtained by targeting the viral receptor protein on the cell surface, thereby blocking the virus from binding to it and gaining entry.
T100 941-1039 Sentence denotes Fortunately, scientists have already uncovered the identity of the viral receptor in cell culture.
T101 1040-1248 Sentence denotes A recent pre-print publication found that the 2019-nCoV uses the angiotensin-converting enzyme 2 (ACE2) as a receptor for cell entry 41, which is the same receptor that the SARS coronavirus uses for entry 42.
T102 1249-1404 Sentence denotes For both viruses, the coronavirus binds to ACE2 through its S protein on the virion, where after fusion of the viral membrane and cell membrane will occur.
T103 1405-1552 Sentence denotes Subsequently, the RNA virus will replicate its genome inside the cell, and ultimately make new virions that will be secreted to infect other cells.
T104 1553-1719 Sentence denotes The coincidence of SARS and 2019-nCoV using ACE2 receptor opens up the possibility of using the extensive research studied on SARS entry and applying it to 2019-nCoV.
T105 1720-1881 Sentence denotes Based on the SARS literature, several potential blocking strategies could be considered, which were shown to be effective in preventing infection in SARS models.
T106 1883-1925 Sentence denotes Blocking agents that bind to ACE2 receptor
T107 1926-2021 Sentence denotes The first strategy would consist of administering to patients an agent that would bind to ACE2.
T108 2022-2163 Sentence denotes The key advantage here is that the host ACE2 protein will not change, so there is no concern about escape from binding the therapeutic agent.
T109 2164-2372 Sentence denotes Moreover, the virus will not have the ability to mutate and bind an entirely new host receptor in the time frame of this outbreak; such functional relationships are established by evolution over long periods.
T110 2373-2575 Sentence denotes By analogy, the influenza virus changes the mutations on its surface to escape antibody neutralization every year, but it always focuses on using sialic acid on the cell surface as an entry receptor 43.
T111 2576-2631 Sentence denotes There are two known options for agents to bind to ACE2.
T112 2632-2801 Sentence denotes The first is using the small receptor-binding domain (RBD) from the SARS S protein that has been shown to be the key domain that binds the ACE2 receptor during entry 44.
T113 2802-2931 Sentence denotes Administration of this domain, 193 amino acids in size, has been shown to effectively block the entry of SARS in cell culture 44.
T114 2932-3085 Sentence denotes It is well within reason that SARS RBD could be given to patients, thereby binding their ACE2 proteins on target cells, preventing infection ( Figure 1).
T115 3086-3195 Sentence denotes There is also the potential for the equivalent RBD of 2019-nCoV to be produced and used as a therapy as well.
T116 3196-3565 Sentence denotes This strategy assumes SARS and 2019-nCoV share the same binding site on ACE2, which is highly likely given the similar ACE2 binding sites of SARS and NL63 coronavirus The small size of the therapy, similar in size in nanobody domains from camelid antibodies, would enhance the perfusion of the biologic into tissues to more effectively bind to viral entry receptors 45.
T117 3566-3749 Sentence denotes In regards to the outbreak situation that is ongoing, the small protein facilitates the rapid production of the therapy in bacteria potentially, which would help production yields 19.
T118 3750-3950 Sentence denotes Moreover, bacterial production would allow RBD proteins to be produced in a wide range of production facilities today in China, which already has numerous contract research organization operations 46.
T119 3951-4109 Sentence denotes Alternatively, the RBD protein could be attached to an Fc fragment for extended circulation, which was done for an equivalent 212 amino acid domain from MERS.
T120 4110-4295 Sentence denotes The MERS RBD-Fc fusion demonstrated the ability to block viral infection toward cell receptors, as well as to stimulate an immune response against that specific viral domain in mice 47.
T121 4296-4471 Sentence denotes Of note, since the RBD-Fc fusion would bind to normal cells, one would want to eliminate cytotoxic Fc domain functions through mutations that eliminate Fc receptor binding 48.
T122 4472-4481 Sentence denotes Figure 1.
T123 4483-4561 Sentence denotes Therapeutic agents that could be used to block 2019-nCoV from infecting cells.
T124 4562-4651 Sentence denotes Target cells expressing ACE2 include lung and gastrointestinal tissues in the human body.
T125 4652-4765 Sentence denotes The large spike protein on the surface of the coronavirus binds to ACE2 on infected cells, leading to cell entry.
T126 4766-4846 Sentence denotes Three proposed strategies would block this interaction would abrogate infection.
T127 4847-5014 Sentence denotes In the first, the receptor-binding domain (RBD) of the spike protein from SARS or 2019-nCoV would be administered, thereby binding ACE2 and saturating available sites.
T128 5015-5141 Sentence denotes Alternatively, an antibody or single chain antibody fragment (scFv) could be administered against ACE2 to accomplish the same.
T129 5142-5277 Sentence denotes A third strategy would target the coronavirus virions directly by using the ACE2 extracellular domain as bait to bind to spike protein.
T130 5278-5370 Sentence denotes An Fc domain fused to ACE2 would facilitate prolonged circulation of the biologic (ACE2-Fc).
T131 5371-5517 Sentence denotes A second, similar strategy would be to administer an antibody that would bind to ACE2 protein, thereby preventing 2019-nCoV infection ( Figure 1).
T132 5518-5608 Sentence denotes This strategy was shown to effectively block SARS entry and replication in experiments 42.
T133 5609-5785 Sentence denotes While no ACE2 antibody sequences are published in literature indexes, monoclonal antibodies do exist and the associated hybridoma sequences could be cloned in a matter of days.
T134 5786-5937 Sentence denotes There would be no concern for any viral escape from an ACE2 binding antibody, which is an advantage over neutralizing approaches against the S protein.
T135 5938-6043 Sentence denotes There are a couple of design considerations when thinking about how to employ the ACE2 antibody strategy.
T136 6044-6195 Sentence denotes Any effector functions would need to be removed from the Fc domain 49, such that inflammation would not be caused in different tissues expressing ACE2.
T137 6196-6290 Sentence denotes This would retain the long-half life endowed by the Fc domain without any of the side effects.
T138 6291-6533 Sentence denotes The downside of including the Fc domain is the need to use a more expensive mammalian cell production system to preserve proper glycosylation, which would decrease the turnaround time for getting the drug to patients in the outbreak scenario.
T139 6534-6634 Sentence denotes Alternatively, one could just administer a single chain variable fragment (scFv) that binds to ACE2.
T140 6635-6709 Sentence denotes A nanobody or VHH domains from camelids are another option as well 50, 51.
T141 6710-6822 Sentence denotes These could be produced in bacteria, and its small size would allow for rapid permeation into different tissues.
T142 6823-6902 Sentence denotes The downside is the shorter half-life of these molecules without the Fc domain.
T143 6903-6954 Sentence denotes There are several limitations to these two options.
T144 6955-7239 Sentence denotes Regarding the SARS RBD strategy, the body would likely develop an immune response to the SARS protein eventually, although the key intervention period of infection to combat 2019-nCoV would fall under this window of time, where after an immune response for both viruses would develop.
T145 7240-7443 Sentence denotes Alternatively, if one were to use the homologous RBD from 2019-nCoV itself, this immune response would likely be very advantageous since it could yield both a blocking effect and a vaccination effect 52.
T146 7444-7673 Sentence denotes For both strategies, the dose that would be needed to block ACE2 receptors in the body across different organs is unknown, and as is the percentage of ACE2 receptors that would need to be saturated in order to slow the infection.
T147 7674-7883 Sentence denotes The number of ACE2 receptors in the body, which are found in lung and gastrointestinal organs along with vascular endothelial cells among other tissues 53, could ultimately prove prohibitive for this strategy.
T148 7884-8033 Sentence denotes Moreover, the turnover of the ACE2 receptor on the cell surface would also influence how often the therapeutic protein would need to be administered.
T149 8034-8211 Sentence denotes To solve this issue, one could increase the concentration of anti-ACE2 therapy at the crucial site of infection in the lungs, via local administration to lungs via nebulization.
T150 8212-8337 Sentence denotes Lastly, there is the possibility that binding ACE2 directly could paradoxically worsen lung physiology and clinical symptoms.
T151 8338-8552 Sentence denotes A study found that a fusion protein of SARS RBD to Fc domain bound ACE2 in murine lung tissue after administration, exacerbating alveolar edema via ACE2 interaction, which normally counteracts acute lung injury 54.
T152 8553-8720 Sentence denotes This suggests that if one were use an ACE2 binding strategy, it would be best employed early during infection or as a prophylaxis to block the initial viral infection.
T153 8721-8810 Sentence denotes Ultimately, clinical trials in patients would need to investigate these potential issues.
T154 8812-8839 Sentence denotes ACE2 immunoadhesin strategy
T155 8840-9014 Sentence denotes A potentially more promising strategy would be to create an antibody-like molecule that would bind to the coronavirus itself, rather than shielding cells from being infected.
T156 9015-9184 Sentence denotes For this strategy, it is proposed to use a soluble version of the ACE2 receptor that would bind to the S protein of 2019-nCoV thereby neutralizing the virus ( Figure 1).
T157 9185-9271 Sentence denotes Again, the research on the SARS virus suggests this strategy is potentially promising.
T158 9272-9370 Sentence denotes Soluble ACE2 receptor was demonstrated to block the SARS virus from infecting cells in culture 42.
T159 9371-9570 Sentence denotes The reported affinity of soluble ACE2 for the SARS S protein was 1.70 nM, which is comparable to the affinities of monoclonal antibodies 55; it is likely that 2019-nCoV has similar affinity for ACE2.
T160 9571-9887 Sentence denotes In order to use ACE2 as a therapy to treat patients, it would be advisable to convert soluble ACE2 into an immunoadhesin format fused to an immunoglobulin Fc domain (ACE2-Fc), thereby extending the lifespan of the circulating molecule, while also recruiting effector functions of the immune system against the virus.
T161 9888-10137 Sentence denotes While not tested in an animal model, a previous study demonstrated that an ACE2 extracellular domain fused to the human IgG1 domain (ACE2-NN-Ig) was effective in neutralizing SARS coronavirus in vitro, with a 50% inhibitory concentration of 2 nM 56.
T162 10138-10256 Sentence denotes This study provides evidence then that ACE2-Fc could similarly inhibit 2019-nCoV in vitro and potentially in patients.
T163 10257-10423 Sentence denotes An additional advantage of using ACE2 as a 2019-nCoV S protein neutralizing agent is that ACE2 administration could also directly treat the pneumonia pathophysiology.
T164 10424-10593 Sentence denotes A portion of patients with SARS and 2019-nCoV infection develop pneumonia, which is characterized by pulmonary edema and acute respiratory distress syndrome (ARDS) 1, 2.
T165 10594-10765 Sentence denotes The viruses may, in part, cause ARDS through viral-induced ACE2 protein shedding and ACE2 protein decreased expression, both of which are mediated by S protein binding 54.
T166 10766-10968 Sentence denotes Administration of recombinant ACE2 protein has been shown to improve acute lung injury through decreasing angiotensin II levels and the hormones subsequent binding to angiotensin II type 1a receptor 57.
T167 10969-11080 Sentence denotes Recombinant ACE2 can also reduce ARDS in respiratory syncytial virus 58 and H5N1 influenza 59 infection models.
T168 11081-11240 Sentence denotes Based on these promising preclinical studies, recombinant human ACE2 (rhACE2) was moved into clinical trials in order to treat ARDS in critically ill patients.
T169 11241-11349 Sentence denotes A phase I trial demonstrated rhACE2 was well tolerated with no effects seen on the cardiovascular system 60.
T170 11350-11503 Sentence denotes A phase II trial demonstrated on-target efficacy in reducing Ang1-8 peptide levels, but did not show significant modulation of respiratory parameters 61.
T171 11504-11720 Sentence denotes It remains to be seen whether rhACE2 administration has the same clinical benefits in treating ARDS that have been seen in animal models, and whether ACE2-Fc administration could alleviate ARDS in 2019-nCoV patients.
T172 11721-11884 Sentence denotes The proposed therapy for 2019-nCoV patients would consist of the extracellular domain of the ACE2 protein fused to a human immunoglobulin G Fc domain ( Figure 2A).
T173 11885-12071 Sentence denotes Studies have shown that the ACE2 amino acids 18 – 615 appear to be sufficient for SARS S protein binding 62, which also covers the peptidase domain necessary for ACE2 enzymatic function.
T174 12072-12268 Sentence denotes It is possible a smaller portion of the extracellular ACE2 domain would be adequate for S protein binding, although a smaller version would lack enzyme activity beneficial in treating lung injury.
T175 12269-12415 Sentence denotes Further studies are needed to define the minimal ACE2 domain necessary for 2019-nCoV S protein binding to construct even smaller ACE2-Fc proteins.
T176 12416-12661 Sentence denotes While we do not know the structure of the 2019-nCoV S protein or how it binds to the ACE2 receptor yet, it is reasonable for now to assume that the same ACE2 protein domains utilized by the SARS virus are also bound by 2019-nCoV to infect cells.
T177 12662-12671 Sentence denotes Figure 2.
T178 12673-12764 Sentence denotes TherapeuticDesign of the ACE2-Fc fusion protein as a therapy against 2019-nCoV coronavirus.
T179 12765-12883 Sentence denotes ( A) The extracellular domain of ACE2 is appended onto the human immunoglobulin Fc domain, including the hinge region.
T180 12884-13015 Sentence denotes The Fc domain facilitates dimerization of two ACE2 domains. ( B) The amino acid sequence of the ACE2-Fc fusion protein is provided.
T181 13016-13116 Sentence denotes The ACE2 domain consists of amino acids 18–615 of the human ACE2 protein (blue; UniProtKB - Q9BYF1).
T182 13117-13226 Sentence denotes The sequence of the human immunoglobulin G isotype 1 constant region is provided (green; UniProtKB - P01857).
T183 13227-13326 Sentence denotes A secretion signal from a human immunoglobin heavy chain is provided (red; UniProtKB - A0A0C4DH39).
T184 13327-13524 Sentence denotes The advantage of the Fc domain is endowing a longer-half life of the drug, which could enable healthcare workers to potentially be given drug doses prophylactically before seeing infected patients.
T185 13525-13730 Sentence denotes Indeed, the half-life of recombinant ACE2 was extended from less than two hours to over one week in mice when formatted as a recombinant ACE2-Fc therapy in a study evaluating treatment for hypertension 63.
T186 13731-14018 Sentence denotes One difference from the prior blocking agent strategies is that the effector functions of the Fc domain could be retained in this molecule, allowing recruitment of dendritic cells, macrophages, and natural killer cells through the CD16 receptor against viral particles or infected cells.
T187 14019-14325 Sentence denotes This may facilitate faster activation of the host antiviral immune response and elimination of the virus, which was illustrated in a SARS mouse model where Fc engaging antibodies were more potent in eliminating SARS via activation of phagocytic cells compared to antibodies that neutralized virus alone 64.
T188 14326-14660 Sentence denotes Overall, the ACE2-Fc fusion protein would have many of the same benefits of a traditional neutralizing antibody that would be sought as a treatment for the infection, but represent one with maximal breadth and potency since the 2019-nCoV could not escape its neutralization, given the same protein is also its receptor for cell entry.
T189 14661-14899 Sentence denotes Indeed, it has been shown that the pathogenicity of SARS versus the more mild human coronavirus NL63 was related to a lower affinity of NL63 for human ACE2 versus SARS, with NL63 S protein reducing ACE2 levels less than SARS S protein 65.
T190 14900-15036 Sentence denotes Therefore, if 2019-nCoV were to try to escape ACE2 neutralization via decreasing affinity, it would mutate into a less pathogenic virus.
T191 15037-15208 Sentence denotes This is similar to the re-emergent SARS virus in 2003-2004, which had lower affinity for human ACE2 and resulted in less severe infection and no secondary transmission 66.
T192 15209-15358 Sentence denotes Thus, 2019-nCoV could be presented with an evolutionary trap when faced with potential ACE2-Fc therapy, leading toward a more benign clinical course.
T193 15359-15587 Sentence denotes To give some additional support to the potential of a receptor-immunoadhesin being a potential antiviral strategy, it should be noted that CD4-Fc or CD4-IgG was one of the early agents developed as a potential HIV medication 67.
T194 15588-15718 Sentence denotes The protein contained the first two domains of the CD4 receptor that are known to bind gp120 on the surface of infected HIV cells.
T195 15719-15786 Sentence denotes CD4-IgG was shown to neutralize HIV in vitro, preventing infection.
T196 15787-15911 Sentence denotes The protein was also safe when administered in patients, although only limited-to-mild clinical benefit was achieved 68, 69.
T197 15912-16250 Sentence denotes Updated enhanced versions of CD4-IgG have been developed that additionally have a small peptide derived from the co-receptor, CCR5, enhancing affinity and giving even more potent neutralizing activity, essentially 100% of HIV isolates and making rhesus macaques resistant to multiple simian-human immunodeficiency virus challenges 70, 71.
T198 16251-16464 Sentence denotes While HIV and 2019-nCoV are very different viruses, with different cell types, kinetics, and clinical courses, the previous results with HIV are encouraging that this could be a therapeutic strategy for 2019-nCoV.
T199 16465-16697 Sentence denotes If anything, 2019-nCoV is likely more amenable to this neutralizing therapy given that the respiratory virus will only cause an acute infection, unlike HIV, which causes chronic infection in hosts with different cellular reservoirs.
T200 16698-16921 Sentence denotes One potential limitation of the ACE2-Fc strategy is that the increase in levels of extracellular ACE2 could have unknown effects on the body, particularly when elevated for a prolonged time via Fc domain extended half-life.
T201 16922-17068 Sentence denotes Small levels of extracellular ACE2 are already secreted by tissues, so the circulation of this extracellular domain would not be unprecedented 72.
T202 17069-17289 Sentence denotes Moreover, recombinant ACE2 protein was well-tolerated by healthy patients in a phase I trial, and by patients with lung injury in a phase II trial, suggesting treating 2019-nCoV patients with ACE2-Fc will also tolerated.
T203 17290-17516 Sentence denotes If investigators are still concerned, critical amino acid(s) for ACE2 peptidase activity could be mutated to abolish the native function of this sequence, while retaining high affinity binding for SARS and 2019-nCoV S protein.
T204 17517-17809 Sentence denotes Indeed, this possibility was previously investigated in generating an ACE2 and IgG1 fusion protein, which showed that mutation of histidine residues at position 374 and 378 of the ACE2 extracellular domain abolished peptidase activity, but retained high affinity binding to SARS S protein 56.
T205 17810-18029 Sentence denotes Of course, ACE2 peptidase mutation would eliminate the beneficial effects from the recombinant protein delivery of ACE2 in treating lung injury, so it is recommended that retaining ACE2 enzyme activity be pursued first.
T206 18030-18262 Sentence denotes Another potential concern is that receptor binding via an antibody format could inadvertently direct 2019-nCoV toward infecting Fc receptor (CD16) positive cells, which has been shown in vitro for neutralizing antibodies in MERS 73.
T207 18263-18365 Sentence denotes It’s unclear what clinical significance this would have, and to what extent this would happen in vivo.
T208 18366-18469 Sentence denotes Ultimately, clinical trials will be needed to delineate any specific side effects of ACE2-Fc treatment.

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T12 8476-8481 Phenotype denotes edema http://purl.obolibrary.org/obo/HP_0000969
T13 8531-8548 Phenotype denotes acute lung injury http://www.orpha.net/ORDO/Orphanet_178320
T14 10397-10406 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T15 10488-10497 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T16 10525-10540 Phenotype denotes pulmonary edema http://purl.obolibrary.org/obo/HP_0100598
T17 10551-10571 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T18 10835-10852 Phenotype denotes acute lung injury http://www.orpha.net/ORDO/Orphanet_178320
T19 13714-13726 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T20 15158-15174 Phenotype denotes severe infection http://purl.obolibrary.org/obo/HP_0032169
T21 16209-16225 Phenotype denotes immunodeficiency http://purl.obolibrary.org/obo/HP_0002721
T22 16635-16652 Phenotype denotes chronic infection http://purl.obolibrary.org/obo/HP_0031035